CorMedix Inc

+0.08 (+1.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)190.05M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.02 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$5.08
50-Day MA$4.98
200-Day MA$7.07
See more pivots

CorMedix Inc Stock, NASDAQ:CRMD

300 Connell Drive, Suite 4200, Berkeley Heights, New Jersey 07922
United States of America
Phone: +1.908.517.9500
Number of Employees: 35


CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.